AAAAAA
Results:
1-16
|
Results: 16
Authors:
GUREVICH EV
JOYCE JN
Citation: Ev. Gurevich et Jn. Joyce, DISTRIBUTION OF DOPAMINE D-3 RECEPTOR-EXPRESSING NEURONS IN THE HUMANFOREBRAIN - COMPARISON WITH D-2 RECEPTOR-EXPRESSING NEURONS, Neuropsychopharmacology, 20(1), 1999, pp. 60-80
Authors:
GUREVICH EV
KORDOWER J
JOYCE JN
Citation: Ev. Gurevich et al., DOPAMINE D2 RECEPTOR MESSENGER-RNA IS EXPRESSED IN MATURING NEURONS OF THE HUMAN HIPPOCAMPAL AND SUBICULAR FIELDS, NeuroReport, 8(16), 1997, pp. 3605-3610
Authors:
JOYCE JN
GUREVICH EV
Citation: Jn. Joyce et Ev. Gurevich, CORTEX AND SEROTONIN IN SCHIZOPHRENIA - EFFECTS OF ANTIPSYCHOTIC TREATMENT, Schizophrenia research, 24(1-2), 1997, pp. 33-34
Authors:
GUREVICH EV
JOYCE JN
Citation: Ev. Gurevich et Jn. Joyce, DOPAMINE D2 RECEPTOR MESSENGER-RNA EXPRESSION IN THE HIPPOCAMPAL-FORMATION OF SCHIZOPHRENICS, Schizophrenia research, 24(1-2), 1997, pp. 86-86
Authors:
NESTEROVA IV
GUREVICH EV
NESTEROV VI
OTMAKHOVA NA
BOBKOVA NV
Citation: Iv. Nesterova et al., BULBECTOMY-INDUCED LOSS OF RAPHE NEURONS IS COUNTERACTED BY ANTIDEPRESSANT TREATMENT, Progress in neuro-psychopharmacology & biological psychiatry, 21(1), 1997, pp. 127-140
Authors:
JOYCE JN
GOLDSMITH SG
GUREVICH EV
Citation: Jn. Joyce et al., LIMBIC CIRCUITS AND MONOAMINE RECEPTORS - DISSECTING THE EFFECTS OF ANTIPSYCHOTICS FROM DISEASE PROCESSES, Journal of Psychiatric Research, 31(2), 1997, pp. 197-217
Authors:
GUREVICH EV
JOYCE JN
Citation: Ev. Gurevich et Jn. Joyce, ALTERATIONS IN THE CORTICAL SEROTONERGIC SYSTEM IN SCHIZOPHRENIA - A POSTMORTEM STUDY, Biological psychiatry, 42(7), 1997, pp. 529-545
Authors:
JOYCE JN
GUREVICH EV
Citation: Jn. Joyce et Ev. Gurevich, ANATOMY OF D2 AND D3 RECEPTOR NEURONS IN THE HUMAN MEDIAL TEMPORAL-LOBE, Biological psychiatry, 41, 1997, pp. 182-182
Authors:
GUREVICH EV
BORDELON Y
SHAPIRO RM
ARNOLD SE
GUR RE
JOYCE JN
Citation: Ev. Gurevich et al., MESOLIMBIC DOPAMINE D-3 RECEPTORS AND USE OF ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA - A POSTMORTEM STUDY, Archives of general psychiatry, 54(3), 1997, pp. 225-232
Authors:
GUREVICH EV
JOYCE JN
Citation: Ev. Gurevich et Jn. Joyce, COMPARISON OF [H-3] PAROXETINE AND [H-3] CYANOIMIPRAMINE FOR QUANTITATIVE MEASUREMENT OF SEROTONIN TRANSPORTER SITES IN HUMAN BRAIN, Neuropsychopharmacology, 14(5), 1996, pp. 309-323
Authors:
GUREVICH EV
JOYCE JN
Citation: Ev. Gurevich et Jn. Joyce, [I-125] RTI-55 BINDING TO THE SEROTONIN TRANSPORTER, [I-125] LSD BINDING TO 5-HT2 AND [H-3] 8-OH-DIPAT BINDING TO 5-HT1A RECEPTORS IN SCHIZOPHRENIC PREFRONTAL CORTEX, Schizophrenia research, 15(1-2), 1995, pp. 59-59
Authors:
JOYCE JN
GUREVICH EV
KUNG HF
KUNG MP
BORDELON Y
SHAPIRO R
ARNOLD SE
GUR RE
Citation: Jn. Joyce et al., DOPAMINE D3 RECEPTORS ARE ELEVATED IN SCHIZOPHRENIC BRAIN AND DECREASED BY NEUROLEPTIC TREATMENT, Schizophrenia research, 15(1-2), 1995, pp. 61-61
Authors:
KATKOV YA
OTMAKHOVA NA
GUREVICH EV
NESTEROVA IV
BOBKOVA NV
Citation: Ya. Katkov et al., ANTIDEPRESSANTS SUPPRESS BULBECTOMY-INDUCED AUGMENTATION OF VOLUNTARYALCOHOL-CONSUMPTION IN C57B1 6J BUT NOT IN DBA/2J MICE/, Physiology & behavior, 56(3), 1994, pp. 501-509
Authors:
GUREVICH EV
KUNG MP
BORDELON Y
JOYCE JN
Citation: Ev. Gurevich et al., MESOLIMBIC DOPAMINE D3 RECEPTORS - ELEVATION IN SCHIZOPHRENICS, Biological psychiatry, 35(9), 1994, pp. 716-716
Authors:
JOYCE JN
GUREVICH EV
Citation: Jn. Joyce et Ev. Gurevich, [H-3] PAROXETINE BINDING IN HUMAN BRAIN - COMPARISON WITH [H-3] CYANOIMIPRAMINE, Biological psychiatry, 35(9), 1994, pp. 728-728
Authors:
GUREVICH EV
ALEKSANDROVA IA
OTMAKHOVA NA
KATKOV YA
NESTEROVA IV
BOBKOVA NV
Citation: Ev. Gurevich et al., EFFECTS OF BULBECTOMY AND SUBSEQUENT ANTIDEPRESSANT TREATMENT ON BRAIN 5-HT2 AND 5-HT1A RECEPTORS IN MICE, Pharmacology, biochemistry and behavior, 45(1), 1993, pp. 65-70
Risultati:
1-16
|